Author Page for Sant Muangnoicharoen

Single Ad26.COV2.S Booster Dose Following Two Doses of BBIBP-CorV Vaccine Against SARS-CoV-2 Infection in Adults: Day 28 Results of a Phase 1/2 Open-Label Trial

Number of pages: 41 Posted: 15 Mar 2023

Sant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, Supitcha Kamolratakul, Saranath Lawpoolsri Niyom, Anan Jongkaewwattana, Arunee Thitithanyanont, Viravarn Luvira, Pailinrut Chinwangso, Narumon Thanthamnu, Narisara Chantratita, Jacqueline Kyungah Lim, T. Anh Wartel, Jean-Louis Excler, Martin F. Ryser, Chloe Leong, Tippi K. Mak and Punnee Pitisutthithum

Mahidol University - Vaccine Trial Centre, Phaholpolpayuhasena Hospital, Thammasat University, Mahidol University, Mahidol University, National Center for Genetic Engineering and Biotechnology, Mahidol University, Mahidol University, Center of Excellence for Biomedical and Public Health Informatics (BIOPHICS), Mahidol University, Mahidol University - Faculty of Tropical Medicine, International Vaccine Institute, International Vaccine Institute, International Vaccine Institute, Janssen Global Medical Affairs, Janssen Asia Pacific Medical Affairs Operations, National University of Singapore (NUS) - Duke-NUS Medical School and Mahidol University - Vaccine Trial Centre

Downloads 59 (970,490)

Abstract:

2.

Immune Responses of Adults Previously Received Two Doses of Inactivated Covid-19 Vaccines, and Third Dose of Any Covid-19 Vaccine Boosted with Bivalent Mrna Ancestral/Omicron Ba.4/5 Vaccine

Number of pages: 28 Posted: 28 Mar 2025

Sant Muangnoicharoen, Saranath Lawpoolsri Niyom, Juthaporn Cowan, Viravarn Luvira, Anan Jongkaewwattana, Sira Nanthapisal, Weerapong Phumratanaprapin, Supitcha Kamolratakul, Narumon Thanthamnu, Chatnapa Duangdee and Punnee Pitisutthithum

Mahidol University - Vaccine Trial Centre, Mahidol University, Mahidol University, Mahidol University - Institute of Human Righs and Peace Studies, National Center for Genetic Engineering and Biotechnology, Thammasat University, Mahidol University, Mahidol University, Mahidol University, Mahidol University and Mahidol University - Vaccine Trial Centre

Downloads 47 (1,097,529)

Abstract:

3.

Immune Responses to a Heterologous Booster with Mrna Based Covid-19 Vaccine after Priming with an Inactivated Newcastle Disease Virus Recombinant Vaccine Expressing the Sars-Cov-2 Spike Protein (Ndv-Hxp-S)

Number of pages: 30 Posted: 21 Jan 2025

Viravarn Luvira, Saranath Lawpoolsri Niyom, Weerapong Phumratanaprapin, Anan Jongkaewwattana, Sira Nanthapisal, Sant Muangnoicharoen, Supitcha Kamolratakul, Yupa Sabmee, Chatnapa Duangdee, Piengthong Narakorn, Surichan S, Laina Mercer, Rama Raghunandan, Christina Polyak, Ponthip Wirachwong, Jorge Flores and Punnee Pitisutthithum

Mahidol University - Institute of Human Righs and Peace Studies, Mahidol University, Mahidol University, National Center for Genetic Engineering and Biotechnology, Thammasat University, Mahidol University - Vaccine Trial Centre, Mahidol University, affiliation not provided to SSRN, Mahidol University, affiliation not provided to SSRN, affiliation not provided to SSRN, Institute for Disease Modeling, PATH, PATH, affiliation not provided to SSRN, PATH and Mahidol University - Vaccine Trial Centre

Downloads 45 (1,121,190)

Abstract:

4.

Heterologous Ad26.Cov2.S Booster after Primary Bbibp-Corv Vaccination Against Sars-Cov-2 Infection: 1-Year Follow-Up of a Phase 1/2 Open-Label Trialheterologous Ad26.Cov2.S Booster after Primary Bbibp-Corv Vaccination Against Sars-Cov-2 Infection: 1-Year Follow-Up of a Phase 1/2 Open-Label Trial

Number of pages: 50 Posted: 24 Jan 2024

Sant Muangnoicharoen, Rakpong Wiangcharoen, Saranath Lawpoolsri, Sira Nanthapisal, Anan Jongkaewwattana, Chatnapa Duangdee, Supitcha Kamolratakul, Viravarn Luvira, Narumon Thanthamnu, Narisara Chantratita, Arunee Thitithanyanont, T. Anh Wartel, Jean-Louis Excler, Martin F. Ryser, Chloe Leong, Tippi K. Mak and Punnee Pitisutthithum

Mahidol University - Vaccine Trial Centre, Phaholpolpayuhasena Hospital, Mahidol University, Thammasat University, National Center for Genetic Engineering and Biotechnology, Hospital for Tropical Diseases, Mahidol University, Mahidol University, Mahidol University, Mahidol University - Faculty of Tropical Medicine, Mahidol University, International Vaccine Institute, International Vaccine Institute, Janssen Global Medical Affairs, Janssen Asia Pacific Medical Affairs Operations, University of Saskatchewan and Mahidol University - Vaccine Trial Centre

Downloads 41 (1,170,409)

Abstract:

5.

Risk Factors for HIV Seroconversion in a High Incidence Cohort of Men Who Have Sex with Men and Transgender Women in Bangkok, Thailand

Number of pages: 53 Posted: 14 Jan 2021

Tanyaporn Wansom, Sant Muangnoicharoen, Sorachai Nitayaphan, Suchai Kitsiripornchai, Trevor A. Crowell, Leilani Francisco, Paileen Gilbert, Dixion Rwakasyaguri, Jittima Dhitavat, Qun Li, David King, Merlin L. Robb, Kirsten Smith, Elizabet A. Heger, Punnee Pitisutthithum, Robert J. O’Connell, Sandhya Vasan and RV348 Study Group

Walter Reed Army Institute of Research - U.S. Military HIV Research Program, Mahidol University - Vaccine Trial Centre, Armed Forces Research Institute of Medical Sciences, Armed Forces Research Institute of Medical Sciences, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, US Army Medical Research Development Command (USAMRDC) - Special Operations Branch, US Army Medical Research Development Command (USAMRDC) - Special Operations Branch, Mahidol University - Vaccine Trial Centre, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, Armed Forces Research Institute of Medical Sciences, US Army Medical Materiel Development Activity, Mahidol University - Vaccine Trial Centre, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, Armed Forces Research Institute of Medical Sciences and Independent

Downloads 39 (1,196,171)

Citation 2

Sant Muangnoicharoen

Mahidol University - Vaccine Trial Centre

5

231

2

Scholarly Papers (5)

Single Ad26.COV2.S Booster Dose Following Two Doses of BBIBP-CorV Vaccine Against SARS-CoV-2 Infection in Adults: Day 28 Results of a Phase 1/2 Open-Label Trial

Abstract:

Immune Responses of Adults Previously Received Two Doses of Inactivated Covid-19 Vaccines, and Third Dose of Any Covid-19 Vaccine Boosted with Bivalent Mrna Ancestral/Omicron Ba.4/5 Vaccine

Abstract:

Immune Responses to a Heterologous Booster with Mrna Based Covid-19 Vaccine after Priming with an Inactivated Newcastle Disease Virus Recombinant Vaccine Expressing the Sars-Cov-2 Spike Protein (Ndv-Hxp-S)

Abstract:

Heterologous Ad26.Cov2.S Booster after Primary Bbibp-Corv Vaccination Against Sars-Cov-2 Infection: 1-Year Follow-Up of a Phase 1/2 Open-Label Trialheterologous Ad26.Cov2.S Booster after Primary Bbibp-Corv Vaccination Against Sars-Cov-2 Infection: 1-Year Follow-Up of a Phase 1/2 Open-Label Trial

Abstract:

Risk Factors for HIV Seroconversion in a High Incidence Cohort of Men Who Have Sex with Men and Transgender Women in Bangkok, Thailand

Abstract: